Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 500 - 1,000Exact Company Size |
Primary Industry | 812 Personal & Laundry Services |
Additional NAICS Codes | 339112 Surgical & Medical Instrument Manufacturing 339113 Surgical Appliance & Supplies Manufacturing |
Address | 1775 West Oak Commons Ct Marietta, GA 30062 |
Mimedx Group | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $10 - $100 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Date | Investors | Percent Raised | Target Size |
---|---|---|---|
January 22, 2016 | 10 | N/A | $0 MM |
Complete list of funding rounds and total amounts in the Company Report |
Trademark | Date |
---|---|
EPIEFFECT Human biological amniotic membrane tissue intended for subsequent implantation; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material | 09/02/2022 |
AXIOFILL Human allograft tissue | 04/14/2022 |
AMNIOEFFECT Human biological amniotic membrane tissue intended for subsequent implantation; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material | 10/20/2021 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
CINTAS | Mason, OH | 100 |
UPBOUND GROUP | Plano, TX | 85 |
DENTAL EXPRESS STAFFING | Wilton, WI | 59 |
SCI SHARED RESOURCES | Houston, TX | 53 |
TEAM PUBLIC CHOICES | San Diego, CA | 50 |
UNIFIRST | Richmond, VA | 47 |
TRION SOLUTIONS | Troy, MI | 45 |
SERVICE CORPORATION INTERNATIONAL | Houston, TX | 40 |
PLUS COMPANY U.S. | San Francisco, CA | 33 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
JACKSON HEALTHCARE GOVERNMENT SERVICES | Alpharetta, GA | 100 |
NORTH AMERICAN ON-SITE | Suwanee, GA | 81 |
MIMEDX GROUP | Marietta, GA | 46 |
GOLDEN HOME SERVICES | Roswell, GA | 40 |
GOLDFEIN | Alpharetta, GA | 25 |
LSGF MANAGEMENT | Peachtree Cornerss, GA | 14 |
Company | Revenue ($ MM) |
---|---|
|